Cara | $8,000,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
Earlyasset | $2,000,000 | (Apr 2, 2026)
Certified by Founder
Lodge
INNOVENTRIC
start up
Israel
- Rehovot
- 30/10/2024
- Series B
- $28,500,000
Innoventric is a Structural Heart medical device company specializing in the development of percutaneous heterotopic cross-caval solutions for Tricuspid Regurgitation and right heart disease.
http://www.innoventric.com
#TTVR #Cardiology #MedTech #InterventionalCardiology #heterotopic #crosscaval #medicaldevices
- Industry Medical Device
- Website https://innoventric.com/
- LinkedIn https://www.linkedin.com/company/innoventric/
Sona(UK) | $45,000,000 | (Apr 2, 2026)
Variance | $21,500,000 | (Apr 2, 2026)
Linx Security | $50,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Quantcore | $3,318,962 | (Apr 2, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)
Semarion | $3,800,000 | (Apr 2, 2026)
Via Separations | $36,000,000 | (Apr 2, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)